TRCT
MDT icon

Tower Research Capital (TRC)’s Medtronic MDT Stock Holding History

Tower Research Capital (TRC)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3M Sell
34,654
-2,894
-8% -$277K 0.08% 257
2025
Q4 		$3.61M Buy
37,548
+22,097
+143% +$2.15M 0.09% 202
2025
Q3 		$1.47M Sell
15,451
-40,835
-73% -$3.75M 0.04% 380
2025
Q2 		$4.91M Buy
56,286
+9,665
+21% +$820K 0.13% 130
2025
Q1 		$4.19M Sell
46,621
-26,507
-36% -$2.37M 0.12% 128
2024
Q4 		$5.84M Buy
73,128
+25,933
+55% +$2.24M 0.12% 135
2024
Q3 		$4.25M Sell
47,195
-44,573
-49% -$3.75M 0.11% 118
2024
Q2 		$7.22M Buy
91,768
+65,135
+245% +$5.34M 0.12% 135
2024
Q1 		$2.32M Sell
26,633
-154,084
-85% -$13.2M 0.06% 245
2023
Q4 		$14.9M Buy
180,717
+140,241
+346% +$10.7M 0.18% 94
2023
Q3 		$3.17M Buy
40,476
+16,574
+69% +$1.39M 0.1% 187
2023
Q2 		$2.11M Buy
23,902
+494
+2% +$42.5K 0.07% 221
2023
Q1 		$1.89M Sell
23,408
-5,701
-20% -$465K 0.06% 217
2022
Q4 		$2.26M Sell
29,109
-97,116
-77% -$7.87M 0.09% 145
2022
Q3 		$10.2M Buy
126,225
+62,937
+99% +$5.66M 0.17% 107
2022
Q2 		$5.68M Sell
63,288
-136,448
-68% -$13.8M 0.13% 129
2022
Q1 		$22.2M Buy
199,736
+124,511
+166% +$13.2M 0.21% 89
2021
Q4 		$7.78M Buy
75,225
+50,320
+202% +$5.83M 0.13% 116
2021
Q3 		$3.12M Buy
24,905
+1,692
+7% +$219K 0.08% 174
2021
Q2 		$2.88M Sell
23,213
-111,288
-83% -$14M 0.08% 202
2021
Q1 		$15.9M Buy
134,501
+98,805
+277% +$11.6M 0.27% 67
2020
Q4 		$4.18M Buy
35,696
+7,559
+27% +$832K 0.13% 97
2020
Q3 		$2.92M Buy
28,137
+9,808
+54% +$985K 0.03% 214
2020
Q2 		$1.68M Buy
18,329
+8,104
+79% +$777K 0.07% 283
2020
Q1 		$923K Buy
+10,225
New +$1.09M 0.06% 244
2019
Q4 		– Sell
-18,722
Closed -$2.03M – 4040
2019
Q3 		$2.03M Sell
18,722
-2,803
-13% -$292K 0.14% 116
2019
Q2 		$2.1M Sell
21,525
-2,499
-10% -$228K 0.14% 109
2019
Q1 		$2.19M Sell
24,024
-10,476
-30% -$938K 0.13% 114
2018
Q4 		$3.14M Buy
34,500
+29,642
+610% +$2.77M 0.23% 90
2018
Q3 		$478K Sell
4,858
-15,548
-76% -$1.44M 0.04% 498
2018
Q2 		$1.75M Buy
+20,406
New +$1.7M 0.1% 191
2018
Q1 		– Sell
-10,143
Closed -$819K – 3602
2017
Q4 		$819K Buy
10,143
+5,256
+108% +$421K 0.11% 195
2017
Q3 		$380K Buy
+4,887
New +$406K 0.03% 366
2017
Q2 		– Sell
-8,135
Closed -$655K – 3146
2017
Q1 		$655K Sell
8,135
-31,374
-79% -$2.45M 0.07% 108
2016
Q4 		$2.81M Buy
39,509
+38,964
+7,149% +$3.06M 0.31% 69
2016
Q3 		$47K Sell
545
-23,872
-98% -$2.08M ﹤0.01% 1181
2016
Q2 		$2.12M Buy
+24,417
New +$1.97M 0.2% 84
2016
Q1 		– Sell
-57
Closed -$4K – 4604
2015
Q4 		$4K Sell
57
-543
-91% -$40.9K ﹤0.01% 3216
2015
Q3 		$40K Sell
600
-3,403
-85% -$251K ﹤0.01% 1178
2015
Q2 		$297K Buy
4,003
+1,203
+43% +$91.9K 0.03% 241
2015
Q1 		$218K Buy
2,800
+2,278
+436% +$173K 0.03% 373
2014
Q4 		$38K Sell
522
-29,985
-98% -$2.08M ﹤0.01% 1189
2014
Q3 		$1.89M Buy
30,507
+28,296
+1,280% +$1.8M 0.21% 91
2014
Q2 		$141K Sell
2,211
-9,648
-81% -$586K 0.02% 732
2014
Q1 		$730K Buy
11,859
+4,883
+70% +$284K 0.09% 160
2013
Q4 		$400K Sell
6,976
-11,326
-62% -$642K 0.07% 238
2013
Q3 		$975K Buy
18,302
+12,936
+241% +$696K 0.11% 174
2013
Q2 		$276K Buy
+5,366
New +$265K 0.02% 191

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tower Research Capital (TRC)'s MDT Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Medtronic (MDT) stake by 7.7% in Q1 2026, selling an estimated $277K and leaving 34,654 shares worth $3M. The position accounts for 0.08% of the portfolio, ranked #257.

Tower Research Capital (TRC) first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $22.2M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Tower Research Capital (TRC) held 34,654 shares of Medtronic worth $3M as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,894 Medtronic shares in Q1 2026, an estimated $277K.
  • Medtronic made up 0.08% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #257 holding.
  • Tower Research Capital (TRC) first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Medtronic position peaked at $22.2M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.